Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19014680)

  • 21. Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.
    Komatsu K; Buchanan FG; Katkuri S; Morrow JD; Inoue H; Otaka M; Watanabe S; DuBois RN
    Gastroenterology; 2005 Aug; 129(2):577-90. PubMed ID: 16083714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism.
    Xu S; Khoo S; Dang A; Witt S; Do V; Zhen E; Schaefer EM; Cobb MH
    Mol Endocrinol; 1997 Oct; 11(11):1618-25. PubMed ID: 9328344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response.
    Kocieniewski P; Lipniacki T
    Phys Biol; 2013 Jun; 10(3):035006. PubMed ID: 23735655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
    Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of MEK2 is sufficient to induce skin papilloma formation in transgenic zebrafish.
    Chou CM; Chen YC; Su S; Chen GD; Huang KY; Lien HW; Huang CJ; Cheng CH
    J Biomed Sci; 2015 Nov; 22():102. PubMed ID: 26572230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition.
    Pinkas J; Leder P
    Cancer Res; 2002 Aug; 62(16):4781-90. PubMed ID: 12183438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.
    Schramek H; Feifel E; Marschitz I; Golochtchapova N; Gstraunthaler G; Montesano R
    Am J Physiol Cell Physiol; 2003 Sep; 285(3):C652-61. PubMed ID: 12900389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MEK1/2 dual-specificity protein kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2012 Jan; 417(1):5-10. PubMed ID: 22177953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin.
    Scholl FA; Dumesic PA; Barragan DI; Charron J; Khavari PA
    Oncogene; 2009 Mar; 28(12):1485-95. PubMed ID: 19198628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo.
    Kim DJ; Lee MH; Reddy K; Li Y; Lim DY; Xie H; Lee SY; Yeom YI; Bode AM; Dong Z
    Carcinogenesis; 2013 May; 34(5):1134-43. PubMed ID: 23354306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAP kinase: it's been longer than fifteen minutes.
    Sturgill TW
    Biochem Biophys Res Commun; 2008 Jun; 371(1):1-4. PubMed ID: 18406346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
    Hoang VT; Matossian MD; La J; Hoang K; Ucar DA; Elliott S; Burks HE; Wright TD; Patel S; Bhatt A; Phamduy T; Chrisey D; Buechlein A; Rusch DB; Nephew KP; Anbalagan M; Rowan B; Cavanaugh JE; Flaherty PT; Miele L; Collins-Burow BM; Burow ME
    J Cell Biochem; 2021 Aug; 122(8):835-850. PubMed ID: 33876843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations.
    Dentici ML; Sarkozy A; Pantaleoni F; Carta C; Lepri F; Ferese R; Cordeddu V; Martinelli S; Briuglia S; Digilio MC; Zampino G; Tartaglia M; Dallapiccola B
    Eur J Hum Genet; 2009 Jun; 17(6):733-40. PubMed ID: 19156172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway.
    Zaheer RS; Koetzler R; Holden NS; Wiehler S; Proud D
    J Immunol; 2009 Apr; 182(8):4854-64. PubMed ID: 19342664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implication of MEK1 and MEK2 in the establishment of the blood-placenta barrier during placentogenesis in mouse.
    Charron J; Bissonauth V; Nadeau V
    Reprod Biomed Online; 2012 Jul; 25(1):58-67. PubMed ID: 22561024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212.
    Jing J; Greshock J; Holbrook JD; Gilmartin A; Zhang X; McNeil E; Conway T; Moy C; Laquerre S; Bachman K; Wooster R; Degenhardt Y
    Mol Cancer Ther; 2012 Mar; 11(3):720-9. PubMed ID: 22169769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine-tuning of MEK signaling is pivotal for limiting B and T cell activation.
    Houde N; Beuret L; Bonaud A; Fortier-Beaulieu SP; Truchon-Landry K; Aoidi R; Pic É; Alouche N; Rondeau V; Schlecht-Louf G; Balabanian K; Espéli M; Charron J
    Cell Rep; 2022 Jan; 38(2):110223. PubMed ID: 35021072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic ras-induced down-regulation of pro-apoptotic protease caspase-2 is required for malignant transformation of intestinal epithelial cells.
    Yoo BH; Wang Y; Erdogan M; Sasazuki T; Shirasawa S; Corcos L; Sabapathy K; Rosen KV
    J Biol Chem; 2011 Nov; 286(45):38894-903. PubMed ID: 21903589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity.
    Emery CM; Monaco KA; Wang P; Balak M; Freeman A; Meltzer J; Delach SM; Rakiec D; Ruddy DA; Korn JM; Haling J; Acker MG; Caponigro G
    Mol Cancer Res; 2017 Oct; 15(10):1431-1444. PubMed ID: 28655712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.
    Scholl FA; Dumesic PA; Barragan DI; Harada K; Bissonauth V; Charron J; Khavari PA
    Dev Cell; 2007 Apr; 12(4):615-29. PubMed ID: 17419998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.